Literature DB >> 18927348

Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.

Seyed Javad Moghaddam1, Huaiguang Li, Sung-Nam Cho, Megan K Dishop, Ignacio I Wistuba, Lin Ji, Jonathan M Kurie, Burton F Dickey, Francesco J Demayo.   

Abstract

Lung cancer is the leading cause of cancer deaths in the United States. In addition to genetic abnormalities induced by cigarette smoke, several epidemiologic studies have found that smokers with chronic obstructive pulmonary disease (COPD), an inflammatory disease of the lungs, have an increased risk of lung cancer (1.3- to 4.9-fold) compared to smokers without COPD. This suggests a link between chronic airway inflammation and lung carcinogenesis, independent of tobacco smoke exposure. We studied this association by assaying the inflammatory impact of products of nontypeable Haemophilus influenzae, which colonizes the airways of patients with COPD, on lung cancer promotion in mice with an activated K-ras mutation in their airway epithelium. Two new mouse models of lung cancer were generated by crossing mice harboring the LSL-K-ras(G12D) allele with mice containing Cre recombinase inserted into the Clara cell secretory protein (CCSP) locus, with or without the neomycin cassette excised (CCSP(Cre) and CCSP(Cre-Neo), respectively). Lung lesions in CCSP(Cre-Neo)/LSL-K-ras(G12D) and CCSP(Cre)/LSL-K-ras(G12D) mice appeared at 4 and 1 month of age, respectively, and were classified as epithelial hyperplasia of the bronchioles, adenoma, and adenocarcinoma. Weekly exposure of CCSP(Cre)/LSL-K-ras(G12D) mice to aerosolized nontypeable Haemophilus influenzae lysate from age 6-14 weeks resulted in neutrophil/macrophage/CD8 T-cell-associated COPD-like airway inflammation, a 3.2-fold increase in lung surface tumor number (156 +/- 9 versus 45 +/- 7), and an increase in total lung tumor burden. We conclude that COPD-like airway inflammation promotes lung carcinogenesis in a background of a G12D-activated K-ras allele in airway secretory cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927348      PMCID: PMC2660561          DOI: 10.1165/rcmb.2008-0198OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  59 in total

1.  Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.

Authors:  R Meuwissen; S C Linn; M van der Valk; W J Mooi; A Berns
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

2.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

Authors:  G H Fisher; S L Wellen; D Klimstra; J M Lenczowski; J W Tichelaar; M J Lizak; J A Whitsett; A Koretsky; H E Varmus
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 4.  NF-kappaB in cancer: from innocent bystander to major culprit.

Authors:  Michael Karin; Yixue Cao; Florian R Greten; Zhi-Wei Li
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

5.  Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis.

Authors:  V Bandi; M A Apicella; E Mason; T F Murphy; A Siddiqi; R L Atmar; S B Greenberg
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

6.  Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway.

Authors:  Beinan Wang; David J Lim; Jiahuai Han; Young S Kim; Carol B Basbaum; Jian-Dong Li
Journal:  J Biol Chem       Date:  2001-11-06       Impact factor: 5.157

Review 7.  Chronic inflammation and cancer.

Authors:  Emily Shacter; Sigmund A Weitzman
Journal:  Oncology (Williston Park)       Date:  2002-02       Impact factor: 2.990

8.  Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription.

Authors:  Hirofumi Jono; Tsuyoshi Shuto; Haidong Xu; Hirofumi Kai; David J Lim; James R Gum; Young S Kim; Shoji Yamaoka; Xin-Hua Feng; Jian-Dong Li
Journal:  J Biol Chem       Date:  2002-09-16       Impact factor: 5.157

9.  Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity.

Authors:  Carlos Caulin; Thao Nguyen; Mary A Longley; Zhijian Zhou; Xiao-Jing Wang; Dennis R Roop
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

10.  Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD.

Authors:  A Di Stefano; G Caramori; T Oates; A Capelli; M Lusuardi; I Gnemmi; F Ioli; K F Chung; C F Donner; P J Barnes; I M Adcock
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

View more
  63 in total

Review 1.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.

Authors:  Cesar E Ochoa; Seyedeh Golsar Mirabolfathinejad; Venado Ana Ruiz; Scott E Evans; Mihai Gagea; Christopher M Evans; Burton F Dickey; Seyed Javad Moghaddam
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-22

3.  NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.

Authors:  Hirokazu Okayama; Motonobu Saito; Naohide Oue; Jonathan M Weiss; Jimmy Stauffer; Seiichi Takenoshita; Robert H Wiltrout; S Perwez Hussain; Curtis C Harris
Journal:  Int J Cancer       Date:  2012-06-13       Impact factor: 7.396

4.  Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.

Authors:  Shanshan Deng; Marco Ramos-Castaneda; Walter V Velasco; Michael J Clowers; Berenice A Gutierrez; Oscar Noble; Yiping Dong; Melody Zarghooni; Lucero Alvarado; Mauricio S Caetano; Shuanying Yang; Edwin J Ostrin; Carmen Behrens; Ignacio I Wistuba; Laura P Stabile; Humam Kadara; Stephanie S Watowich; Seyed Javad Moghaddam
Journal:  Carcinogenesis       Date:  2020-11-13       Impact factor: 4.944

Review 5.  Inhaled innate immune ligands to prevent pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Cory J Fox; Nidhi Sachdev; Leonid Gibiansky; Burton F Dickey
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

6.  Tumorigenic Th17 cells in oncogenic Kras-driven and inflammation-accelerated lung cancer.

Authors:  Seon Hee Chang
Journal:  Oncoimmunology       Date:  2015-01-30       Impact factor: 8.110

7.  Oncogenic KRAS confers chemoresistance by upregulating NRF2.

Authors:  Shasha Tao; Shue Wang; Seyed Javad Moghaddam; Aikseng Ooi; Eli Chapman; Pak K Wong; Donna D Zhang
Journal:  Cancer Res       Date:  2014-10-22       Impact factor: 12.701

Review 8.  Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Authors:  Katrin Eurich; Mayuko Segawa; Satoko Toei-Shimizu; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

9.  IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.

Authors:  Mauricio S Caetano; Huiyuan Zhang; Amber M Cumpian; Lei Gong; Nese Unver; Edwin J Ostrin; Soudabeh Daliri; Seon Hee Chang; Cesar E Ochoa; Samir Hanash; Carmen Behrens; Ignacio I Wistuba; Cinthya Sternberg; Humam Kadara; Carlos Gil Ferreira; Stephanie S Watowich; Seyed Javad Moghaddam
Journal:  Cancer Res       Date:  2016-04-01       Impact factor: 12.701

10.  Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice.

Authors:  Konstantinos Doris; Sophia P Karabela; Chrysoula A Kairi; Davina Cm Simoes; Charis Roussos; Spyros G Zakynthinos; Ioannis Kalomenidis; Timothy S Blackwell; Georgios T Stathopoulos
Journal:  Respir Res       Date:  2010-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.